Sarepta Therapeutics, Inc. (SRPT) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before August 25, 2025

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=155054&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

Levi & Korsinsky Notifies Compass Group Diversified Holdings, LLC (CODI) Investors – Lead Plaintiff Deadline on July 8, 2025

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=155050&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at

Lost Money on Rocket Companies, Inc. (RKT)? Contact Levi & Korsinsky to Join Class Action Before July 8, 2025

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Rocket Companies, Inc. (NYSE:RKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://www.zlk.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=155055&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Automotive Tire Pressure Monitoring System Market Set to Hit USD 8.94 Billion in 2024, Accelerating Ahead with a Robust 12.91% CAGR Through 2032 | AnalystView Market Insights

San Francisco, USA, July 01, 2025 (GLOBE NEWSWIRE) — Market Dynamics The Automotive Tire Pressure Monitoring System (TPMS) market was valued at US$ 8,940.29 million in 2024 and is projected to grow at a robust CAGR of 12.91% from 2025 to 2032, reflecting increasing global emphasis on vehicle safety and performance. This impressive growth trajectory

/DISREGARD RELEASE: Acre NY Realty/

We are advised by a representative of Acre NY Realty that journalists and other readers should disregard the news release, Queens' First Five-Star Hotel, The Westin Flushing LaGuardia Airport, Has Its Grand Opening in Flushing, issued June 9, 2025 over PR Newswire. There are errors within the information that was originally provided. SOURCE Acre NY

Greenstein & Pittari, LLP Warns New Yorkers About the Hidden Dangers of Toxic Mold Exposure

Greenstein & Pittari, LLP, a premier New York City personal injury law firm, is raising urgent public awareness about the severe health consequences and legal risks associated with toxic mold exposure in residential and workplace settings. Often hidden behind walls, under floors, or inside HVAC systems, toxic mold thrives in damp, poorly ventilated environments-and it's

Dr. Michael Lebow Launches Nationwide Scholarship Initiative to Support Aspiring Healthcare Professionals in the United States

ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) — The Dr. Michael Lebow Scholarship for Future Doctors is now officially open for applications, inviting undergraduate students across the United States to compete for a one-time academic award designed to support and encourage future leaders in the healthcare field. This prestigious scholarship, created by esteemed vascular surgeon Dr.

Dr. Michael Lebow Launches Nationwide Scholarship Initiative to Support Aspiring Healthcare Professionals in the United States

Dr. Michael Lebow Launches Nationwide Scholarship Initiative to Support Aspiring Healthcare Professionals in the United States GlobeNewswire July 01, 2025 ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) — The Dr. Michael Lebow Scholarship for Future Doctors is now officially open for applications, inviting undergraduate students across the United States to compete for a one-time academic award

Nektar Therapeutics Announces Pricing of $100 Million Public Offering

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its underwritten public offering of $100 million of shares of its common stock. Nektar is selling 4,255,320 shares of common stock in the offering. The shares of common stock are

Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:ABEO), CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On June 30, 2025, the Compensation Committee of Abeona's Board of Directors granted restricted stock

Scroll to Top